期刊文献+

吡格列酮通过上调PPARγ降低创伤性脑损伤大鼠脑组织炎性细胞因子的水平 被引量:3

Pioglitazone decreases the levels of inflammatory cytokines in SD rats with traumatic brain injury via up-regulating PPARγ
下载PDF
导出
摘要 目的观察吡格列酮对创伤性脑损伤(TBI)大鼠过氧化物酶体增殖物激活受体γ(PPARγ)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)mRNA的表达影响及量效关系。方法 72只SD雄性大鼠随机分为正常组、假手术组、对照组、(0.5、1.0、10.0)mg/kg吡咯列酮组,每组各12只。改良Feeney法制作TBI模型,假手术组只开孔不进行打击处理,治疗组按体质量分别给予(0.5、1.0、10.0)mg/kg吡咯列酮治疗,对照组和假手术组给等量安慰剂。致伤24、48 h后,采用反转录PCR检测脑损伤部位组织PPARγ、TNF-α、IL-6的mRNA水平。结果损伤24 h后,各吡格列酮组PPARγmRNA表达量显著上调,不同剂量吡咯列酮组间PPARγmRNA表达量差异显著,有剂量依赖性;损伤后治疗组TNF-αmRNA的表达量显著下调,24 h后,与0.5 mg/kg组相比,(1.0、10.0)mg/kg吡咯列酮组TNF-α、IL-6的mRNA水平降低。结论吡格列酮上调TBI大鼠PPARγmRNA、下调TNF-α和IL-6 mRNA表达,抑制炎症反应。 Objective To observe the effect of pioglitazone on the levels of peroxisome proliferator activated receptor γ( PPARγ),tumor necrosis factor-α( TNF-α) and interleukin 6( IL-6) mRNAs and the dose-dependent relationship in rats with traumatic brain injury( TBI). Methods A total of 72 male SD rats were randomly divided into a normal group,a sham operation group,a control group and three pioglitazone groups receiving doses of 0. 5,1. 0 and 10. 0 mg/kg,with 12 rats in each group. Modified Feeney's free falling method was used to make TBI models; the sham operation group only had an operation but without combat; the pioglitazone groups were given pioglitazone at the doses of 0.5,1.0 and 10.0 mg/kg,respectively;the control group and sham operation group were given equal amount of placebo. The levels of PPARγ,TNF-α and IL-6mRNAs in lesion brain tissues were detected by reverse transcription PCR 24 and 48 hours after injury. Results Twenty-four hours after the injury,the expression of PPARγ mRNA was up-regulated significantly in all pioglitazone groups,with significant difference between each pioglitazone group in a dose-dependent manner. The expression of TNF-α mRNA was significantly down-regulated in the treatment groups after injury. Twenty-four hours after the injury,the levels of TNF-α and IL-6 mRNAs in the pioglitazone groups receiving the doses of 1. 0 and 10. 0 mg/kg decreased compared with those in the group receiving 0. 5 mg/kg pioglitazone. Conclusion Pioglitazone inhibits inflammatory reaction by up-regulating the level of PPARγ mRNA and down-regulating the levels of TNF-α and IL-6 mRNAs in rats with TBI.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2016年第2期182-184,190,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 重庆市卫生局科技基金(渝教科文2010-5)
关键词 吡格列酮 创伤性脑损伤 过氧化物酶体增殖物激活受体γ(PPARγ) 白细胞介素6 肿瘤坏死因子α pioglitazone traumatic brain injury peroxisome proliferator activated receptor γ interleukin 6 tumor necrosis factor α
  • 相关文献

参考文献26

  • 1Craft S, Watson G S. Insulin and neurodegenerative disease: shared and specific mechanisms [ J ]. Lancet Neurol, 2004, 3 ( 3 ) : 169 - 178.
  • 2Jennings J S, Gerber A M, Vallano M L. Pharmacological strategies for neumpmtection in traumatic brain injury [ J ]. Mini Rev Med Chem, 2008, 8(7) : 689 -701.
  • 3Onyszchuk G, He Y Y, Berman N E, et al. Detrimental effects of aging on out come from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice [ J ]. J Neurotrauma, 2008, 25(2) : 153 -171.
  • 4McTigue D M, Tripathi R, Wei P, et al. The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury [ J ]. Exprimental Neurology, 2007, 205 ( 2 ) : 396 - 406.
  • 5Singh R K, Gupta B, Tripathi K, et al. Anti oxidant potential of meffonnin and pioglitazone in type 2 diabetes mellitus: Beyond their anti glycemic effect [J]. Diabetes Metab Syndr, 2015 Aug 24. pii: S1871 - 4021 ( 15 ) 00083 - 1. doi: 10. 1016/j. dsx. 2015.08. 016. [ Epub ahead of print ].
  • 6Yokoyama H, Araki S, Kawai K, et al. Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease ( JDDM 36) [ J ]. Diabetes Res C/in Pract, 2015, 109(3 ) : 485 -492.
  • 7Mojt~aedzad~ M, Lee M L, Friedman T C. Cor~immfioo or discontimmfioo of pio~itazooe when starting bedtime insulin in patients with poorly controlled type 2 diabetes in an inner-city pop~afion[ J]. J Diabetes Complications, 2015, 29(8) : 1248 - 1252.
  • 8Pi~povi~c K, ~.upan ~, Dolenec P, et al. A single dose of PPAR'y agonist piaglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats [ J ]. Prog Neuropsychopharmacol Biol Psychiatry, 2015, 59:8 -20.
  • 9Pmkash A, Kumar A. Role d nuclear recept~ on regulation d BDNF and neuroinflammation in hippocampus of ~-amyloid animal model of Aizheimer~ disease[ J]. Neurotox Res, 2014, 25(4) : 335 -347.
  • 10Papi A, De Carolis S, Bertoni S, et al. PPART and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche[J]. J Cell Physiol, 2014, 229(11) : 1595 -1606.

二级参考文献21

  • 1曹泽玲,叶平,龙超良,陈凯,李小卫,汪海.吡格列酮对大鼠心脏缺血再灌注损伤的保护作用[J].中国临床药理学与治疗学,2005,10(10):1112-1117. 被引量:15
  • 2刘尊敬,龙涛,王国相,焦劲松,刘运海,杨期东,田朝晖,徐文艳.PPAPγ和缺血再灌注脑组织损伤关系的研究[J].中风与神经疾病杂志,2006,23(6):644-646. 被引量:7
  • 3Kalsekar I,Iyer S,Mody R,et al.Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population[J].J Manag Care Pharm,2006,12:121-129.
  • 4Kiyota Y,Kondo T,Maeshiba Y,et al.St udies on the metabolism of the new antidiabetic agent pioglitazone.Identification of metabolites in rats and dogs[J].Arzneimittel forschung,1997,47:22-28.
  • 5Stumvoll M,Haring HU.Glitazones:clinical effects and molecular mechanisms[J].Ann Med,2002,34:217-224.
  • 6Fujiwara T,Yoshioka S,Yoshioka T,et al.Characterization of new oral antidiabetic agent CS-045:studies in KK and ob/ob mice and Zucker fatty rats[J].Diabetes,1988,37:1549-1558.
  • 7Schwartz S,Raskin P,Fonseca V,et al.Effects of troglitazone in insulin-treated patients with type Ⅰ idiabetes mellitus:Troglitazone and exogenous Insulin Study Group[J].N Engl J Med,1998,338:861-866.
  • 8Kurtz TW.New treatment strategies for patients with hypertension and insulin resistance[J].Am J Med,2006,119:24-30.
  • 9Derosa G,Cicero AF,Dangelo A,et al.Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride[J].Hypertens Res,2005,28:917-924.
  • 10Gimble JM,Robinson M.Peroxisome proliferatoractivated receptor-activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells[J].Mol Pharmacol,1996,50:1087-1094.

共引文献27

同被引文献14

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部